The reasons for the mixed results of clinical trials of vitamin D3 supplementation in stroke patients could be due to problems with choosing the right doses of this secosteroid, unknown functional state of VDR in the treated patients, shorter or longer follow-up times, and various cutoff values for vitamin D deficiency. Here, VDR is linked to vitamin D deficiency.